Literature DB >> 10413031

Increased vulnerability of NFH-LacZ transgenic mouse to traumatic brain injury-induced behavioral deficits and cortical damage.

M Nakamura1, K E Saatman, J E Galvin, U Scherbel, R Raghupathi, J Q Trojanowski, T K McIntosh.   

Abstract

The authors evaluated the neurobehavioral and neuropathologic sequelae after traumatic brain injury (TBI) in transgenic (TG) mice expressing truncated high molecular weight neurofilament (NF) protein fused to beta-galactosidase (NFH-LacZ), which develop Lewy body-like NF-rich inclusions throughout the CNS. TG mice and their wild-type (WT) littermates were subjected to controlled cortical impact brain injury (TG, n = 19; WT, n = 17) or served as uninjured controls (TG, n = 11; WT, n = 11). During a 3-week period, mice were evaluated with an array of neuromotor function tests including neuroscore, beam balance, and both fast and slow acceleration rotarod. Brain-injured WT and TG mice showed significant motor dysfunction until 15 days and 21 days post-injury, respectively (P<.025). Compared with brain-injured WT mice, brain-injured TG mice had significantly greater motor dysfunction as assessed by neuroscore (P<.01) up to and including 15 days post-injury. Similarly, brain-injured TG mice performed significantly worse than brain-injured WT mice on slow acceleration rotarod at 2, 8, and 15 days post-injury (P<.05), and beam balance over 2 weeks post-injury (P<.01). Histopathologic analysis showed significantly greater tissue loss in the injured hemisphere in TG mice at 4 weeks post-injury (P<.01). Together these data show that NFH-LacZ TG mice are more behaviorally and histologically vulnerable to TBI than WT mice, suggesting that the presence of NF-rich inclusions may exacerbate neuromotor dysfunction and cell death after TBI.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10413031     DOI: 10.1097/00004647-199907000-00006

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN: 0271-678X            Impact factor:   6.200


  10 in total

1.  Repetitive mild brain trauma accelerates Abeta deposition, lipid peroxidation, and cognitive impairment in a transgenic mouse model of Alzheimer amyloidosis.

Authors:  Kunihiro Uryu; Helmut Laurer; Tracy McIntosh; Domenico Praticò; Daniel Martinez; Susan Leight; Virginia M-Y Lee; John Q Trojanowski
Journal:  J Neurosci       Date:  2002-01-15       Impact factor: 6.167

2.  Suppression of inflammatory and neuropathic pain by uncoupling CRMP-2 from the presynaptic Ca²⁺ channel complex.

Authors:  Joel M Brittain; Djane B Duarte; Sarah M Wilson; Weiguo Zhu; Carrie Ballard; Philip L Johnson; Naikui Liu; Wenhui Xiong; Matthew S Ripsch; Yuying Wang; Jill C Fehrenbacher; Stephanie D Fitz; May Khanna; Chul-Kyu Park; Brian S Schmutzler; Bo Myung Cheon; Michael R Due; Tatiana Brustovetsky; Nicole M Ashpole; Andy Hudmon; Samy O Meroueh; Cynthia M Hingtgen; Nickolay Brustovetsky; Ru-Rong Ji; Joyce H Hurley; Xiaoming Jin; Anantha Shekhar; Xiao-Ming Xu; Gerry S Oxford; Michael R Vasko; Fletcher A White; Rajesh Khanna
Journal:  Nat Med       Date:  2011-06-05       Impact factor: 53.440

3.  Kollidon VA64, a membrane-resealing agent, reduces histopathology and improves functional outcome after controlled cortical impact in mice.

Authors:  Lamin H Mbye; Eyup Keles; Luyang Tao; Jimmy Zhang; Joonyong Chung; Mykol Larvie; Rajani Koppula; Eng H Lo; Michael J Whalen
Journal:  J Cereb Blood Flow Metab       Date:  2011-11-16       Impact factor: 6.200

4.  A simple, efficient tool for assessment of mice after unilateral cortex injury.

Authors:  Shirley B Shelton; David B Pettigrew; Alison D Hermann; Weidong Zhou; Patrick M Sullivan; Keith A Crutcher; Kenneth I Strauss
Journal:  J Neurosci Methods       Date:  2007-11-19       Impact factor: 2.390

5.  TrkB gene transfer does not alter hippocampal neuronal loss and cognitive deficits following traumatic brain injury in mice.

Authors:  Valeria Conte; Ramesh Raghupathi; Deborah J Watson; Scott Fujimoto; Nicolas C Royo; Niklas Marklund; Nino Stocchetti; Tracy K McIntosh
Journal:  Restor Neurol Neurosci       Date:  2008       Impact factor: 2.406

6.  Recovery of neurological function despite immediate sleep disruption following diffuse brain injury in the mouse: clinical relevance to medically untreated concussion.

Authors:  Rachel K Rowe; Jordan L Harrison; Bruce F O'Hara; Jonathan Lifshitz
Journal:  Sleep       Date:  2014-04-01       Impact factor: 5.849

7.  Comparative neuroprotective effects of cyclosporin A and NIM811, a nonimmunosuppressive cyclosporin A analog, following traumatic brain injury.

Authors:  Lamin H A N Mbye; Indrapal N Singh; Kimberly M Carrico; Kathryn E Saatman; Edward D Hall
Journal:  J Cereb Blood Flow Metab       Date:  2008-08-20       Impact factor: 6.200

8.  Functional outcome is impaired following traumatic brain injury in aging Nogo-A/B-deficient mice.

Authors:  N Marklund; D Morales; F Clausen; A Hånell; O Kiwanuka; A Pitkänen; D A Gimbel; O Philipson; L Lannfelt; L Hillered; S M Strittmatter; T K McIntosh
Journal:  Neuroscience       Date:  2009-06-23       Impact factor: 3.590

Review 9.  Protein accumulation in traumatic brain injury.

Authors:  Douglas H Smith; Kunihiro Uryu; Kathryn E Saatman; John Q Trojanowski; Tracy K McIntosh
Journal:  Neuromolecular Med       Date:  2003       Impact factor: 3.843

10.  In vivo targeting of a variant causing vanishing white matter using CRISPR/Cas9.

Authors:  Anne E J Hillen; Martina Hruzova; Tanja Rothgangl; Marjolein Breur; Marianna Bugiani; Marjo S van der Knaap; Gerald Schwank; Vivi M Heine
Journal:  Mol Ther Methods Clin Dev       Date:  2022-02-23       Impact factor: 6.698

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.